The convergence of cord blood stem cell reprogramming into induced pluripotent stem cells (iPSCs), development of off-the-shelf CAR-NK (Chimeric Antigen Receptor Natural Killer) cellular immunotherapies, and automated bio-vault storage defines the future scope of the Stem Cell Umbilical Cord Blood Market. Cryopreserved cord blood cells serve as pristine starting material for generating...